SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Procter&Gamble Healt reports Profit after tax of Rs 411.90 Mln, in the June 2022 quarter

29 Aug 2022 Evaluate
A minor change in the total revenue was seen in the June 2022 quarter. The total revenue for the quarter stood at Rs. 2958.90 millions against Rs. 2854.00 millions during year ago period.Profit saw a slight increase of 21.54%to Rs. 411.90  millions from Rs. 338.90 millions.OP of the company witnessed a marginal growth to 621.40 millions from 508.70 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202206 202106 % Var
Sales 2958.90 2854.00 3.68 11144.10 10087.30 10.48 11144.10 10087.30 10.48
Other Income 31.00 24.20 28.10 131.90 181.00 -27.13 131.90 181.00 -27.13
PBIDT 621.40 508.70 22.15 2808.70 2641.20 6.34 2808.70 2641.20 6.34
Interest 0.20 1.80 -88.89 4.20 8.00 -47.50 4.20 8.00 -47.50
PBDT 621.20 506.90 22.55 2804.50 2633.20 6.51 2804.50 2633.20 6.51
Depreciation 74.70 71.60 4.33 270.80 300.40 -9.85 270.80 300.40 -9.85
PBT 546.50 435.30 25.55 2533.70 2332.80 8.61 2533.70 2332.80 8.61
TAX 134.60 96.40 39.63 608.50 564.80 7.74 608.50 564.80 7.74
Deferred Tax 11.30 -37.70 -129.97 0.40 -49.00 -100.82 0.40 -49.00 -100.82
PAT 411.90 338.90 21.54 1925.20 1768.00 8.89 1925.20 1768.00 8.89
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 166.00 0.00
PBIDTM(%) 21.00 17.82 17.82 25.20 26.18 -3.74 25.20 26.18 -3.74

Procter&Gamble Healt Share Price

5021.30 29.00 (0.58%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×